Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

VIVUS Announces Marketing Approval of Avanafil in the Russian Federation for the Treatment of Erectile Dysfunction

firstwordpharmaMarch 15, 2019

Tag: Vivus , Avanafil , Erectile Dysfunction

PharmaSources Customer Service